Lisa A. Locklear

Chief Financial Officer at Longeveron.

Earliest Form D on file: Mar 2026

Filed Mar 25, 2026

Longeveron

Bone marrow cell therapy for heart defects and frailty

Biotech, Miami FL

Signed as Chief Financial Officer

$15.89M

sold of $33.515M offered

Network

At Longeveron

9 people

Joshua M. Hare
Executive Officer, Director
Devin Blass
Executive Officer
George Paletta, Jr.
Director
Nataliya Agafonova
Executive Officer
Paul Lehr
Executive Officer
Rock Soffer
Director

3 more at Longeveron